McCartt Jason, Ross Samuel Wade, Cunningham Kyle W, Wang Huaping, Sealey Leslie, Brake Julia, Christmas Ashley, Sachdev Gaurav, Green John, Thomas Bradley W
Department of Surgery, Wake Forest School of Medicine, Atrium Health Carolinas Medical Center, Charlotte, NC, USA.
Am Surg. 2025 Apr;91(4):579-586. doi: 10.1177/00031348241308907. Epub 2024 Dec 19.
BackgroundThe traditional treatment of traumatic hemothorax (HTX) is large bore chest tubes (CT) ≥28Fr. Recent evidence shows 14Fr pigtail catheters are as effective in drainage of HTX as larger CT. However, this has not been shown in 14Fr Thal tubes, a straight chest tube placed utilizing Seldinger technique.MethodsA single center, prospective randomized controlled trial was performed at an ACS verified Level 1 trauma center comparing 14Fr Thal CT (14CT) to 28Fr CT (28CT) between May 2017 and September 2021. The primary outcome was failure of drainage of hemothorax requiring additional intervention. Secondary outcomes included duration of chest tube placement, length of stay, tube-specific complications, and 90-day hospital readmission. Farrington-Manning approach was used for non-inferiority tests. Wilcoxon 2-samples test or test was used for continuous variables, and Pearson chi-square or Fisher exact test was used for categorical variables.Results109 patients were included in the randomized trial. There were 54 patients in the 14CT cohort, and 55 patients in the 28CT cohort. The primary outcome of drainage failure was similar between groups (8.3% 14CT vs 3.9% 28CT). Using a 15% non-inferiority margin 14CT is non-inferior to 28CT. No differences were identified in secondary outcomes.Conclusion14Fr Thal tubes have similar efficacy in drainage of traumatic hemothorax when compared with 28Fr chest tubes with similar complication rates (NCT03167723).
背景
创伤性血胸(HTX)的传统治疗方法是使用≥28Fr的大口径胸管(CT)。最近的证据表明,14Fr猪尾导管在引流HTX方面与较大的胸管一样有效。然而,在14Fr Thal导管(一种采用Seldinger技术放置的直胸管)方面尚未得到证实。
方法
在一家经美国外科医师学会(ACS)认证的一级创伤中心进行了一项单中心、前瞻性随机对照试验,比较了2017年5月至2021年9月期间14Fr Thal胸管(14CT)和28Fr胸管(28CT)。主要结局是血胸引流失败需要额外干预。次要结局包括胸管留置时间、住院时间、特定导管并发症和90天内再次入院情况。采用Farrington-Manning方法进行非劣效性检验。连续变量采用Wilcoxon双样本检验或检验,分类变量采用Pearson卡方检验或Fisher精确检验。
结果
109例患者纳入随机试验。14CT组有54例患者,28CT组有55例患者。两组间引流失败的主要结局相似(14CT组为8.3%,28CT组为3.9%)。采用15%的非劣效性界值,14CT不劣于28CT。次要结局未发现差异。
结论
与28Fr胸管相比,14Fr Thal导管在创伤性血胸引流方面具有相似的疗效,并发症发生率相似(NCT03167723)。